Clostridium difficile colitis associated with infant botulism: Near- fatal case analogous to Hirschsprung's enterocolitis

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 367-374

  Schechter, Robert ^a,b,c,d   Peterson, Bradley ^a,b,c   McGee, James ^a,b,c   Idowu, Olajire ^a,b,c   Bradley, John ^a,b,c  

^a Division of Communicable Disease Control   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; METRONIDAZOLE; VANCOMYCIN;

ARTICLE; ASCITES; BACTERIUM DETECTION; BOTULISM; CASE REPORT; CLOSTRIDIUM DIFFICILE; COLON OBSTRUCTION; DISEASE ASSOCIATION; FEMALE; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0032806024     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520217     Document Type: Article

References (48)

1. 1. Cooperstock M, Riegle L, Woodruff CW, Onderdonk A. Influence of age, sex, and diet on asymptomatic colonization of infants with Clostridium difficile. J Clin Microbiol 1983;17:830-3.
2. 2. Cooperstock M, Riegle L, Fabacher D, Woodruff CW. Relationship between fecal alpha 1-antitrypsin and colonization with Clostridium difficile in asymptomatic infants. J Pediatr 1985;107:257-9.
3. 3. Dansinger ML, Johnson S, Jansen PC, Opstad NL, Bettin KM, Gerding DN. Protein-losing enteropathy is associated with Clostridium difficile diarrhea but not with asymptomatic colonization; a prospective, case-control study. Clin Infect Dis 1996;22:932-7.
4. 4. Thomas DF, Fernie DS, Bayston R, Spitz L, Nixon HH. Enterocolitis in Hirschsprung's disease: a controlled study of the etiologic role of Clostridium difficile. J Pediatr Surg 1986;21:22-5.
5. 5. Bagwell CE, Langham MR Jr, Mahaffey SM, Talbert JL, Shandling B. Pseudomembranous colitis following resection for Hirschsprung's disease. J Pediatr Surg 1992;27:1261-4.
6. 6. Brearly S, Armstrong GR, Nairn R, et al. Pseudomembranous colitis: a lethal complication of Hirschsprung's disease unrelated to antibiotic usage. J Pediatr Surg 1987;22:257-9.
7. 7. Arnon SS. Clinical trial of botulism immune globulin. In: DasGupta BR, ed. Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects. New York: Plenum Press, 1993:477-82.
8. 8. Edmond BJ, Guerra FA, Blake J, Hempler S. Case of infant botulism in Texas. Tex Med 1977;73:85-8.
9. 9. Edmund BJ. Clostridia species and necrotizing enterocolitis [letter]. Am J Dis Child 1979;133:971.
10. 10. Just I, Wilm M, Selzer J, et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995;270: 13932-6.
11. 11. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995;375:500-3.
12. 12. Wilkins TD, Lyerly DM. Clostridium difficile toxins attack Rho. Trends Microbiol 1996;4:49-51.
13. 13. Lima AA, Lyerly DM, Wilkins TD, Innes DJ, Guerrant RL. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun 1988;56:582-8.
14. 14. Zwiener RJ, Belknap WM, Quan R. Severe pseudomembranous enterocolitis in a child: case report and literature review. Pediatr Infect Dis J 1989;8:876-82.
15. 15. Drapkin MS, Worthington MC, Chang TW, Razvi SA. Clostridium difficile colitis mimicking acute peritonitis. Arch Surg 1985;120:1321-2.
16. 16. Triadafilopoulos G, Hallstone AE. Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 1991;101:685-91.
17. 17. McGregor JA, Soper DE, Lovell G, Todd JK. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989;161: 987-95.
18. 18. Bitti A, Mastrantonio P, Spigaglia P, et al. A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J Clin Pathol 1997;50:259-60.
19. 19. Qualman SJ, Petric M, Karmali MA, Smith CR, Hamilton SR. Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis. Am J Clin Pathol 1990;94:410-6.
20. 20. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-84.
21. 21. Mills DC, Arnon SS. The large intestine as the site of Clostridium botulinum colonization in human infant botulism. J Infect Dis 1987; 156:997-8.
22. 22. Kothare SV, Kassner EG. Infant botulism: a rare cause of colonic ileus. Pediatr Radiol 1995;25:24-6.
23. 23. Adler SP, Chandrika T, Berman WF. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Am J Dis Child 1981;135:820-2.
24. 24. Church JM, Fazio VW. A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile. Dis Colon Rectum 1986;29: 804-9.
25. 25. Spika JS, Shaffer N, Hargrett-Bean N, Collin S, MacDonald KL, Blake PA. Risk factors for infant botulism in the United States. Am J Dis Child 1989;143:828-32.
26. 26. Schwarz PJ, Arnon JM, Arnon SS. Epidemiological aspects of infant botulism in California, 1976-1991. In: DasGupta BR, ed. Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects. New York: Plenum Press, 1993:503-4.
27. 27. Toma S, Lesiak G, Magus M, Lo HL, Delmee M. Serotyping of Clostridium difficile. J Clin Microbiol 1988;26:426-8.
28. 28. Flegel WA, Muller F, Daubener W, Fischer HG, Hadding U, Northoff H. Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B. Infect Immun 1991;59:3659-66.
29. 29. Melo Filho AA, Souza MH, Lyerly DM, Cunha FQ, Lima AA, Ribeiro RA. Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophages. Toxicon 1997;35:743-52.
30. 30. Eriksson S, Aronsson B. Medical implications of nosocomial infection with Clostridium difficile. Scand J Infect Dis 1989;21:733-4.
31. 31. Bogomoletz WV. Fibrin thrombi, a cause of clindamycin-associated colitis? Gut 1976;17:483-7.
32. 32. Aronsson B, Blomback M, Eriksson S, Egberg N. Low levels of coagulation inhibitors in patients with Clostridium difficile infection. Infection 1992;20:58-60.
33. 33. Knot EA, ten Cate JW, Bruin T, Iburg AH, Tytgat GN. Antithrombin III metabolism in two colitis patients with acquired antithrombin III deficiency. Gastroenterology 1985;89:421-5.
34. 34. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133: 770-6.
35. 35. Robson AM. Isolated disturbances in concentrations of electrolytes. In: Berhman RE, ed. Nelson textbook of pediatrics. 14th ed, Philadelphia: W. B. Saunders, 1992:208-11.
36. 36. Dandona P, Fonseca V, Baron DN. Hypoalbuminaemic hyponatraemia: a new syndrome? Br Med J (Clin Res Ed) 1985;291:1253-5.
37. 37. Lyerly DM, Lockwood DE, Richardson SH, Wilkins TD. Biological activities of toxins A and B of Clostridium difficile. Infect Immun 1982;35:1147-50.
38. 38. Gong MC, Iizuka K, Nixon G, et al. Role of guanine nucleotide-binding proteins - ras-family or trimeric proteins or both - in Ca2 + sensitization of smooth muscle. Proc Natl Acad Sci USA 1996;93:1340-5.
39. 39. Levy M, Koren G, Dupuis L, Read SE. Vancomycin-induced red man syndrome. Pediatrics 1990;86:572-80.
40. 40. Hyams JS, Treem WR, Etienne NL, et al. Effect of infant formula on stool characteristics of young infants. Pediatrics 1995;95:50-4.
41. 41. Kim K, Pickering LK, DuPont HL, Sullivan N, Wilkins T. In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. J Infect Dis 1984;150:57-62.
42. 42. Rolfe RD, Song W. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding. J Med Microbiol 1995;42:10-9.
43. 43. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
44. 44. American Academy of Pediatrics. Clostridium difficile. In: Peter G, ed. 1997 red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1997: 177-8.
45. 45. Salcedo J, Keates S, Pothoulakis C, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997;41:366-70.
46. 46. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991;118:633-7.
47. 47. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271:1913-8.
48. 48. Lyerly DM, Bostwick EF, Binion SB, Wilkins TD. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991; 59:2215-8.